Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
GlaxoSmithKline
ClinicalTrials.gov Identifier:
NCT01607086
First received: May 24, 2012
Last updated: November 3, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2008
  Primary Completion Date: July 2008 (Final data collection date for primary outcome measure)